Clinical trial
Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses
NCT02373371 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses
- Lead sponsor
- University Hospital, Limoges
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 25, 2015
- Completion date
- June 1, 2018
- Enrollment
- 26 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
actinic keratoses